Table 1.
Maternal and neonatal clinical characteristics of COVID-19-positive pregnant woman with fetal demise diagnosis. Hospital Santo Tomas, Panama 2020
| Maternal information | |
|---|---|
| Date of stillbirth | September 2020 |
| Maternal age (years) | 20 |
| Maternal history | Unremarkable |
| Gravidity | 3 |
| Parity | 2 |
| Gestational age (weeks) | 27 |
| Clinical severity | Asymptomatic |
| Type of delivery | Vaginal |
| Physical exam | |
| Temperature (°C) | 36.8 |
| Blood pressure (mmHg) | 108/64 |
| Heart rate (BPM) | 81 |
| Respiratory rate (CPM) | 16 |
| Oxygen saturation (%) | 97 |
| Laboratory findings | Normal range |
| Hemoglobin (g/dL) | 11.9 (10.9–14.3) |
| Hematocrit (%) | 35 (31.2–41.9) |
| Leukocytes (× 10^3/µL) | 10.6 (3.8–11.8) |
| Neutrophils (× 10^3/µL) | 3 (1.9–8.2) |
| Lymphocytes (× 10^3/µL) | 2.4 (1.1–3.1) |
| Platelets (× 10^3/µL) | 374 (179–408) |
| Fibrinogen (mg/dL) | 492 (248–506) |
| Virology and microbiology | |
| Nasopharingeal SARS CoV-2 RT PCR | Positive |
| Syphillis | Negative |
| HIV | Negative |
| Other TORCH | Negative a |
| Ultrasound findings | |
| Fetal growth | Normal |
| Fetal weight (g) | 968 |
| Amniotic fluid volume | Normal |
| Placental abruption | No sign |
| Preterm rupture of membranes | No sign |
| Neonatal information | Normal range |
| Sex | Male |
| Birthweight (g) | 992 |
| Birthweight percentile (%) | 40 (10–90) |
| Fronto-occipital circumference (cm) | 24 |
| Fronto-occipital circumference percentile (%) | 25 (10–90) |
| Crown-rump length (cm) | 24 |
| Virology | |
| SARS-CoV-2 RT‒PCR on fetus | Not done |
| SARS-CoV-2 RT‒PCR on placental tissue | Negative |
| Fetal autopsy | Not perfomed |
aPatient declared negative for TORCH agents based on clinical history and hospital laboratory results during the data collection. Abbreviations: BPM Beats per minute, COVID-19 Coronavirus disease 2019, CPM Cycles per minute, HIV Human immunodeficiency virus, RT‒PCR Reverse transcription polymerase chain reaction, SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2, TORCH Toxoplasmosis, other agents, rubella, cytomegalovirus, and herpes simplex